KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $432.3 million.

  • CareDx's Liabilities and Shareholders Equity fell 936.68% to $432.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 30.82%. This contributed to the annual value of $491.0 million for FY2024, which is 518.91% up from last year.
  • CareDx's Liabilities and Shareholders Equity amounted to $432.3 million in Q3 2025, which was down 936.68% from $444.3 million recorded in Q2 2025.
  • CareDx's 5-year Liabilities and Shareholders Equity high stood at $566.6 million for Q4 2021, and its period low was $432.3 million during Q3 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $514.8 million (2023), whereas its average is $508.9 million.
  • In the last 5 years, CareDx's Liabilities and Shareholders Equity soared by 24520.3% in 2021 and then plummeted by 1435.22% in 2024.
  • CareDx's Liabilities and Shareholders Equity (Quarter) stood at $566.6 million in 2021, then dropped by 4.17% to $543.0 million in 2022, then dropped by 14.03% to $466.8 million in 2023, then rose by 5.19% to $491.0 million in 2024, then decreased by 11.96% to $432.3 million in 2025.
  • Its last three reported values are $432.3 million in Q3 2025, $444.3 million for Q2 2025, and $489.6 million during Q1 2025.